PE104798A1 - Compuestos utiles para la inhibicion de la enzima farnesilo transferasa - Google Patents
Compuestos utiles para la inhibicion de la enzima farnesilo transferasaInfo
- Publication number
- PE104798A1 PE104798A1 PE1998000505A PE00050598A PE104798A1 PE 104798 A1 PE104798 A1 PE 104798A1 PE 1998000505 A PE1998000505 A PE 1998000505A PE 00050598 A PE00050598 A PE 00050598A PE 104798 A1 PE104798 A1 PE 104798A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- aryl
- formula
- tumor cells
- farnesilo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 210000004881 tumor cell Anatomy 0.000 abstract 3
- 101100240521 Caenorhabditis elegans nhr-16 gene Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 201000002528 pancreatic cancer Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UN COMPUESTO BENZOCICLOHEPTANO PIRIDINA DE FORMULA (1.0), O SOLVATO, DONDE a ES N o NO; NO MAS DE DOS DE Ra, Rb, Rc Y Rd SON H Y EL RESTO SON HALO, ALQUILO, ALCOXI Y NO MAS DE 2 SON H; R ES H, -S(O)2R1, -S(O)2NR1R2, ENTRE OTROS, R1 Y R2 SON H, ALQUILO, ARILO, ENTRE OTROS; Re Y Rf SON H, ALQUILO, ALQUILOXIALQUILO, ENTRE OTROS; o Re ES H, ALQUILO o ARILO Y Rf ES -(CH2)n-R15, n ES 0-8; R15 ES -C(O)NH2, -SO2NH2, ARILO o -C(=A)-B; B ES OH o NH2 Y A ES NH, O, NOH o NCN o Re Y Rf JUNTO A N FORMAN UN ANILLO HETEROCICLOALQUILO DE 5-6 MIEMBROS OPCIONALMENTE SUSTITUIDO CON OH, NH2, NHR16, ENTRE OTROS; Rh ES H o =O, SI Rh ES H Y Rb Y Rd SON H, GRUPO DE FORMULA (a, b); o Re ES H Y Rf ES UN GRUPO DE FORMULA (c, d, e). EL COMPUESTO I PUEDE SER UTIL PARA INHIBIR EL DESARROLLO ANORMAL DE CELULAS TUMORALES QUE EXPRESAN EL ONCOGEN RAS ACTIVADO, PUDIENDO SER LAS CELULAS TUMORALES PANCREATICAS, CELULAS DE CANCER DE PULMON, CELULAS DE TUMOR DE LEUCEMIA MIELOIDE, CELULAS DE TUMORES FOLICULARES DE TIROIDES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87774197A | 1997-06-17 | 1997-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE104798A1 true PE104798A1 (es) | 1999-11-06 |
Family
ID=25370618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000505A PE104798A1 (es) | 1997-06-17 | 1998-06-15 | Compuestos utiles para la inhibicion de la enzima farnesilo transferasa |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0989983B1 (es) |
| JP (1) | JP2002504144A (es) |
| KR (1) | KR100640672B1 (es) |
| CN (1) | CN1266433A (es) |
| AR (1) | AR012991A1 (es) |
| AT (1) | ATE273299T1 (es) |
| AU (1) | AU753658B2 (es) |
| CA (1) | CA2293714C (es) |
| DE (1) | DE69825589T2 (es) |
| ES (1) | ES2224408T3 (es) |
| HU (1) | HUP0003138A3 (es) |
| IL (2) | IL133386A0 (es) |
| MY (1) | MY143570A (es) |
| NZ (1) | NZ501376A (es) |
| PE (1) | PE104798A1 (es) |
| TW (1) | TW587935B (es) |
| WO (1) | WO1998057960A1 (es) |
| ZA (1) | ZA985203B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002533335A (ja) * | 1998-12-18 | 2002-10-08 | シェーリング コーポレイション | ファルネシルタンパク質トランスフェラーゼインヒビター |
| US6372747B1 (en) | 1998-12-18 | 2002-04-16 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US6362188B1 (en) | 1998-12-18 | 2002-03-26 | Schering Corporation | Farnesyl protein transferase inhibitors |
| US6800636B2 (en) | 1998-12-18 | 2004-10-05 | Schering Corporation | Farnesyl protein transferase inhibitors |
| JP2002533336A (ja) | 1998-12-18 | 2002-10-08 | シェーリング コーポレイション | 三環式ファルネシルタンパク質トランスフェラーゼインヒビター |
| US6432959B1 (en) * | 1998-12-23 | 2002-08-13 | Schering Corporation | Inhibitors of farnesyl-protein transferase |
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| AU2002236813A1 (en) * | 2001-01-22 | 2002-07-30 | Schering Corporation | Treatment of malaria with farnesyl protein transferase inhibitors |
| AU2002257114A1 (en) * | 2001-04-06 | 2002-10-21 | Schering Corporation | Treatment of malaria with farsenyl protein transferase inhibitors |
| CA2499732A1 (en) * | 2002-09-20 | 2004-04-15 | Applied Research Systems Ars Holding N.V. | Piperazine derivatives and methods of use |
| MX2007007074A (es) | 2004-12-13 | 2007-09-04 | Schering Corp | Inhibidores novedosos de proteina transferasa de farnesilo y su uso para tratar cancer. |
| JP2008523148A (ja) | 2004-12-14 | 2008-07-03 | シェーリング コーポレイション | ファルネシルプロテイントランスフェラーゼインヒビターおよび増殖性疾患を処置するための方法 |
| EP2807153B1 (en) * | 2012-01-25 | 2020-03-25 | Novartis AG | Heterocyclic compounds and methods for their use |
| WO2018093695A1 (en) | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | FACTOR XIIa INHIBITORS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW308594B (es) * | 1993-10-15 | 1997-06-21 | Schering Corp | |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| IL117797A0 (en) * | 1995-04-07 | 1996-08-04 | Pharmacopeia Inc | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| US5712280A (en) * | 1995-04-07 | 1998-01-27 | Schering Corporation | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
-
1998
- 1998-06-15 ZA ZA985203A patent/ZA985203B/xx unknown
- 1998-06-15 AU AU80580/98A patent/AU753658B2/en not_active Ceased
- 1998-06-15 PE PE1998000505A patent/PE104798A1/es not_active Application Discontinuation
- 1998-06-15 DE DE69825589T patent/DE69825589T2/de not_active Expired - Lifetime
- 1998-06-15 AT AT98928886T patent/ATE273299T1/de not_active IP Right Cessation
- 1998-06-15 EP EP98928886A patent/EP0989983B1/en not_active Expired - Lifetime
- 1998-06-15 CA CA002293714A patent/CA2293714C/en not_active Expired - Fee Related
- 1998-06-15 IL IL13338698A patent/IL133386A0/xx active IP Right Grant
- 1998-06-15 KR KR1019997011842A patent/KR100640672B1/ko not_active IP Right Cessation
- 1998-06-15 HU HU0003138A patent/HUP0003138A3/hu unknown
- 1998-06-15 NZ NZ501376A patent/NZ501376A/en not_active IP Right Cessation
- 1998-06-15 CN CN98808124A patent/CN1266433A/zh active Pending
- 1998-06-15 JP JP50449099A patent/JP2002504144A/ja not_active Ceased
- 1998-06-15 WO PCT/US1998/011495 patent/WO1998057960A1/en active IP Right Grant
- 1998-06-15 TW TW087109501A patent/TW587935B/zh not_active IP Right Cessation
- 1998-06-15 ES ES98928886T patent/ES2224408T3/es not_active Expired - Lifetime
- 1998-06-16 AR ARP980102862A patent/AR012991A1/es unknown
- 1998-06-16 MY MYPI98002697A patent/MY143570A/en unknown
-
1999
- 1999-12-08 IL IL133386A patent/IL133386A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0989983A1 (en) | 2000-04-05 |
| EP0989983B1 (en) | 2004-08-11 |
| CA2293714C (en) | 2009-09-08 |
| HUP0003138A2 (hu) | 2001-06-28 |
| KR20010013822A (ko) | 2001-02-26 |
| AU8058098A (en) | 1999-01-04 |
| IL133386A0 (en) | 2001-04-30 |
| CA2293714A1 (en) | 1998-12-23 |
| IL133386A (en) | 2006-12-10 |
| AR012991A1 (es) | 2000-11-22 |
| ZA985203B (en) | 1999-01-05 |
| CN1266433A (zh) | 2000-09-13 |
| DE69825589T2 (de) | 2005-09-08 |
| KR100640672B1 (ko) | 2006-11-02 |
| ES2224408T3 (es) | 2005-03-01 |
| ATE273299T1 (de) | 2004-08-15 |
| AU753658B2 (en) | 2002-10-24 |
| HUP0003138A3 (en) | 2002-11-28 |
| TW587935B (en) | 2004-05-21 |
| JP2002504144A (ja) | 2002-02-05 |
| WO1998057960A1 (en) | 1998-12-23 |
| NZ501376A (en) | 2002-03-28 |
| DE69825589D1 (de) | 2004-09-16 |
| MY143570A (en) | 2011-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE104798A1 (es) | Compuestos utiles para la inhibicion de la enzima farnesilo transferasa | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| CY1106223T1 (el) | Μεθοδοι διαμορφωσης λειτουργιας σepινης/θρεονινης πρωτεϊνης κινασης με βασισμενες σε 5-αζακινοξαλινη ενωσεις | |
| DE3162445D1 (de) | 3-aryloxy-3-phenylpropylamines | |
| DK1106179T3 (da) | Anvendelse af östrogenantagonister og östrogenagonister til hæmning af patologiske tilstande | |
| NO972909L (no) | Substituerte azetidin-2-oner for behandling av atherosklerose | |
| ES2180271T3 (es) | Colorantes de trifendioxazina para el teñido de substratos organicos. | |
| AR241531A1 (es) | Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables. | |
| AU7748687A (en) | Phenolic corrosion inhibitors for coating materials | |
| DK199885A (da) | Amidinohydrazoner af tetralin-, chromon-, thiochromon- og tetrahydroquinolin-derivater, fremgangsmaader til deres fremstilling samt deresanvendelse i laegemidler | |
| SE7906638L (sv) | Peptidderivat | |
| DK162044C (da) | Fungicidt indanylbenzamidderivat, fremgangsmaade til fremstilling heraf samt fungicidt middel indeholdende det | |
| SV1997000035A (es) | Acetilenos de biaril como inhibisores de matrices metaloproteasas | |
| CO4940417A1 (es) | DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| ES528961A0 (es) | Procedimiento para la obtencion de piridinas 3-substituidas | |
| NO20000423L (no) | Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| BR9813923A (pt) | N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos | |
| CO4890850A1 (es) | Derivados de 6-pirrolidin-2-ilpiridinas, su reparacion y preparacion en terapeutica. | |
| DK0667863T3 (da) | 2-Perhalogenalkyl-substituerede benzimidazoler, deres fremstilling samt deres anvendelse som pesticider | |
| ID27500A (id) | Senyawa-senyawa organik | |
| DK293890A (da) | 3-oe2,(4-arylpiperazin1-yl)-ethoxylaap-cymen, derivater deraf, som er ortho-, meta- og paramonosubstituerede eller -disubstituerede paa phenylringen, fremgangsmaade til fremstilling af saadanne derivater samt laegemidler, hvori forbindelserne er til stede som det aktive middel | |
| PE20040711A1 (es) | Compuestos de haloalqueno, proceso para su produccion y pesticidas que los contienen | |
| BR9807920A (pt) | Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência | |
| TH31326A (th) | อนุพันธ์ 2-(3h)-ออกซาโซโลนตัวใหม่ | |
| PT100104A (pt) | Processo para a preparacao de aminoalcanos substituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |